Page last updated: 2024-11-05

pentamethylbenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Pentamethylbenzene is a white, crystalline solid with a melting point of 52.5 °C and a boiling point of 231 °C. It is an aromatic hydrocarbon with the molecular formula C11H16. It is a highly substituted benzene derivative, making it a valuable building block for the synthesis of other organic compounds. Pentamethylbenzene is commonly synthesized by the Friedel-Crafts alkylation of benzene with tert-pentyl chloride in the presence of a Lewis acid catalyst, such as aluminum chloride. It is also a byproduct of the production of other aromatic compounds, such as toluene and xylenes. Pentamethylbenzene has been studied for its potential applications in various fields, including materials science, medicine, and catalysis. For example, it has been used as a precursor to produce high-performance polymers, such as polyimides and polyamides. It is also used as a catalyst in the synthesis of other organic compounds, such as pharmaceuticals and pesticides. Researchers study pentamethylbenzene to understand the effects of multiple substituents on the reactivity and properties of aromatic compounds. They are also investigating its potential use as a renewable energy source. Furthermore, it is being explored for its potential applications in the field of organic electronics, such as organic light-emitting diodes (OLEDs) and organic solar cells. The presence of multiple methyl groups on the benzene ring makes it a highly electron-rich compound, which contributes to its unique properties and potential applications.'

Cross-References

ID SourceID
PubMed CID12784
CHEBI ID38998
MeSH IDM0117186

Synonyms (33)

Synonym
nsc1889
1,3,4,5-pentamethylbenzene
pentamethylbenzene ,
benzene, pentamethyl-
700-12-9
nsc-1889
1,2,3,4,5-pentamethylbenzene
inchi=1/c11h16/c1-7-6-8(2)10(4)11(5)9(7)3/h6h,1-5h
benzene, 1,2,3,4,5-pentamethyl-
pentamethylbenzene, 98%
pentamethylbenzol
CHEBI:38998
P0043
AKOS000121593
A836735
1,2,3,4,5-pentamethyl-benzene
nsc 1889
einecs 211-837-8
h6jld3ai98 ,
unii-h6jld3ai98
FT-0602450
DTXSID6061024
W-111706
mfcd00008522
F0001-1815
benzene, 1,2,3,4,5-pentamethyl-; benzene, pentamethyl- (8ci,9ci); 1,2,3,4,5-pentamethylbenzene; nsc 1889; pentamethylbenzene
CS-W010978
Q424944
CS-17338
AMY4088
EN300-21222
benzene, 1,2,3,4,5-pentamethyl- benzene,pentamethyl- pentamethyl-benzen 1,2,3,4,5-pentamethylbenzene pentamethyl phenyl
Z104494472
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
methylbenzeneAny alkylbenzene that is benzene substituted with one or more methyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.49 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]